FDA User Fee Bill Eyes Drug Shortages, New Antibiotics

Law360, New York (March 30, 2012, 4:56 PM EDT) -- Provisions aimed at preventing drug shortages and encouraging the development of new antibiotics will likely be included in this year's must-pass bill reauthorizing U.S. Food and Drug Administration user fees, according to drafts released Thursday by a key Senate health committee.

The drafts show that the Senate Committee on Health, Education, Labor and Pensions is considering language that would require drug manufacturers to report any potential shortages to the FDA six months in advance, as well as incentives for drug manufacturers to develop new antibiotics to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.